← Evidence map

ReviewCancer drug resistance (Alhambra, Calif.)2023

Immune checkpoint inhibitors in ovarian cancer: where do we go from here?

Won-Hee Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37457131